Pharsight

Ezallor Sprinkle patents expiration

Can you believe EZALLOR SPRINKLE received compensation for the extended wait time during the regulatory approval process?
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10413543 SUN PHARM Stable multiparticulate pharmaceutical composition of rosuvastatin
Feb, 2036

(11 years from now)

Ezallor Sprinkle is owned by Sun Pharm.

Ezallor Sprinkle contains Rosuvastatin Calcium.

Ezallor Sprinkle has a total of 1 drug patent out of which 0 drug patents have expired.

Ezallor Sprinkle was authorised for market use on 18 December, 2018.

Ezallor Sprinkle is available in capsule;oral dosage forms.

The generics of Ezallor Sprinkle are possible to be released after 12 February, 2036.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using ROSUVASTATIN CALCIUM ingredient

Market Authorisation Date: 18 December, 2018

Treatment: NA

Dosage: CAPSULE;ORAL

More Information on Dosage

EZALLOR SPRINKLE family patents

Family Patents